USPRegulatory IntelligenceStandardHIGH INSPECTION RISK
USP <795>

Pharmaceutical Compounding — Nonsterile Preparations

The compendial standard for compounding nonsterile preparations: personnel training and evaluation, facilities and equipment, component selection, master formulation and compounding records, beyond-use dating, and quality assurance. The revised chapter became official 1 November 2023.

LAST REVISED
November 2023
PRODUCT AREAS
Solid Dose
SCOPE & APPLICABILITY

Any setting compounding nonsterile preparations — community and health-system pharmacies, physician offices, and 503B facilities for their nonsterile work.

KEY REQUIREMENTS
  • 01Designated person responsible for the compounding programme
  • 02Documented training and periodic competency assessment for compounding personnel
  • 03Master formulation records and per-batch compounding records
  • 04BUDs assigned per the chapter defaults or a documented stability justification
  • 05Defined facility and equipment controls appropriate to nonsterile compounding
IMPLEMENTATION TIPS
Confirm what your state has actually adopted and in which version — adoption lags and varies, and the state text governs
Treat BUD justification as a records exercise: the default table is defensible, a longer date needs data
Keep the master formulation record separate from the compounding record; conflating them is a routine finding
REVISION NOTES

Revised chapter official 1 November 2023, alongside the revised <797>.

USP <795>: frequently asked questions

Quick answers to common questions about USP <795>.

What is USP <795>?

USP <795> — Pharmaceutical Compounding — Nonsterile Preparations — is a standard issued by the United States Pharmacopeia (United States / International). The compendial standard for compounding nonsterile preparations: personnel training and evaluation, facilities and equipment, component selection, master formulation and compounding records, beyond-use dating, and quality assurance. The revised chapter became official 1 November 2023.

Who does USP <795> apply to?

Any setting compounding nonsterile preparations — community and health-system pharmacies, physician offices, and 503B facilities for their nonsterile work.

What are the key requirements of USP <795>?

USP <795> requires, among other things: Designated person responsible for the compounding programme; Documented training and periodic competency assessment for compounding personnel; Master formulation records and per-batch compounding records; BUDs assigned per the chapter defaults or a documented stability justification.

When was USP <795> last updated?

The current version of USP <795> dates from November 2023. Revised chapter official 1 November 2023, alongside the revised <797>.

RELATED STANDARDS
RELATED FDA RECALLS
where Documentation & Change Control control fails
See all Documentation & Change Control recalls →

Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

THIS STANDARD IN PRACTICE

Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.

Weekly Briefing

Track the standards that move

When USP <795> — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.

Read a past issue →